Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
UCB sells anti-haemorrhagic drug to Eumedica 10-February-2009
UCB, 02/11/09
UCB announced that it has agreed to sell world-wide rights to its anti-haemorrhagic product Somatostatine-UCB(TM) to Eumedica.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Personalized Medicine Market To Grow 11% Annually
PharmExec, 12/16/09
Generic drugs dominate market, look to expand into biologics
Formulary , 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09
Article Search
Sponsor